Results 51 to 60 of about 206,766 (202)

Factors influencing attitudes toward vaccine safety and vaccine effectiveness amongst UK healthcare professionals prior to and at the time of COVID-19 vaccine rollout: Insights from the CoPE-HCP cohort study

Human Vaccines & Immunotherapeutics, 2023
Given the potential for nosocomial outbreaks, we must understand factors associated with negative vaccine attitudes amongst healthcare professionals (HCPs) before the rollout of a newly developed vaccine in a pandemic setting. The aim of this prospective
George Collett, Thomas Godec, Ajay K. Gupta   +2 more
doaj   +1 more source

Integrated Analysis of the Safety Experience in Adults with the Bivalent Respiratory Syncytial Virus Prefusion F Vaccine

Vaccines
Background/objectives: This was a post hoc analysis of safety data across the bivalent respiratory syncytial virus prefusion F (RSVpreF) vaccine clinical trial development program. Methods: Data from eight clinical trials in 46,913 immunocompetent adults
Kumar Ilangovan, David Radley, Michael Patton, Emma Shittu, Maria Maddalena Lino, Christos Goulas, Kena A. Swanson, Annaliesa S. Anderson, Alejandra Gurtman, Iona Munjal   +9 more
doaj   +1 more source

Disease Burden and Inpatient Management of Children with Acute Respiratory Viral Infections during the Pre-COVID Era in Germany: A Cost-of-Illness Study

Viruses
Respiratory viral infections (RVIs) are common reasons for healthcare consultations. The inpatient management of RVIs consumes significant resources. From 2009 to 2014, we assessed the costs of RVI management in 4776 hospitalized children aged 0–18 years
Maren Alchikh, Tim O. F. Conrad, Patrick E. Obermeier, Xiaolin Ma, Brunhilde Schweiger, Onya Opota, Barbara A. Rath   +6 more
doaj   +1 more source

Global pandemic preparedness: learning from the COVID-19 vaccine development and distribution

Expert Review of Vaccines
Introduction The COVID-19 pandemic catalyzed unprecedented vaccine innovation, revealing critical shortcomings in achieving equitable vaccine access and underscoring the need for a focused review of the lessons learned to inform future pandemic ...
Suneth Agampodi, Ondari D. Mogeni, Rebecca Chandler, Megha Pansuriya, Jerome H. Kim, Jean-Louis Excler   +5 more
doaj   +1 more source

Assessment of parental perception of malaria vaccine in Tanzania [PDF]

, 2015
Clinical trials of the RTS,S malaria vaccine have completed Phase III and the vaccine is on track for registration. Before making decisions about implementation, it is essential to prepare the ground for introducing the vaccine by assessing awareness and
Marcel Tanner, Idda Romore, Hassan Mshinda, Abdulla, Salim, Romore, Idda, Ali Mohamed Ali, Salim Abdulla, Semali, Innocent, Ali, Ali Mohamed, Innocent Semali, Mshinda, Hassan, Tanner, Marcel   +11 more
core   +1 more source

Closing the Diagnostic Gap in Encephalitis and Acute Disseminated Encephalomyelitis through Digital Case Classification and Viral Metagenomics

Microbiology Research
Encephalitis and acute disseminated encephalomyelitis (ADEM) are often caused or triggered by viruses—but the specific pathogen commonly remains unidentified in routine care.
Patrick E. Obermeier, Xiaolin Ma, Albert Heim, Barbara A. Rath   +3 more
doaj   +1 more source

Safety of the recombinant cholera toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in pregnancy [PDF]

, 2012
INTRODUCTION: Mass vaccinations are a main strategy in the deployment of oral cholera vaccines. Campaigns avoid giving vaccine to pregnant women because of the absence of safety data of the killed whole-cell oral cholera (rBS-WC) vaccine.
Jin Kyung Park (78612), Jacqueline L. Deen (148731), Mohammad Ali, Abdul A. Saleh, Saleh, A. A., Na Yoon Chang (148714), Rita Reyburn (130140), Stephen Obaro (148749), Sunheang Shin (148734), Anna Lena Lopez, Sack, D., Kamala Thriemer, Said M. Ali, Ramadhan Hashim (148699), Ahmed M. Khatib (130136), David Sack, Lorenz von Seidlein, Anna Lena Lopez (92298), Aguado, M. T., Raymond Hutubessy (130149), Godwin Enwere, Shaame, A. J., Ahmed M. Khatib, Maria Teresa Aguado (148740), Godwin Enwere (148705), Abdul A. Saleh (148759), Attiye J Shaame, Raymond Hutubessy, John D. Clemens, Park, J. K., Jacqueline L. Deen, Sunheang Shin, Said M Ali, Abdul A Saleh, Attiye J. Shaame, Mohammad Ali (73095), Jiddawi, M. S., Maria Teresa Aguado, Na Yoon Chang, Rita Reyburn, Lena Lopez, Schaetti, C., John D. Clemens (148728), Attiye J. Shaame (148753), Marie Paule Kieny, Khatib, A. M., Reyburn, R., Ley, B., Shin, S., Lopez, A. L., Mohamed S. Jiddawi (148765), Deok Ryun Kim, Stephen Obaro, Thriemer, K., Ahmed M Khatib, Jacqueline L Deen, Clemens, J. D., Kieny, M. P., Mohamed S Jiddawi, Ali, S. M., Hashim, R., John D Clemens, David Sack (148746), Enwere, G., Chang, N. Y., Deok Ryun Kim (78610), Ramadhan Hashim, Benedikt Ley, Mohamed S. Jiddawi, Ali, M., Deen, J. L., Benedikt Ley (148722), von Seidlein, L., Hutubessy, R., Christian Schaetti (130127), Kim, D. R., Christian Schaetti, Lorenz von Seidlein (45473), Kamala Thriemer (148725), Obaro, S., Marie Paule Kieny (148743), Said M. Ali (130132), Jin Kyung Park   +82 more
core   +1 more source

Vaccine Safety

, 2017
“Are vaccines safe?” has become one of the most hotly contested and politically charged questions in contemporary culture, fueled in no small part by voracious online debates, peer-to-peer influence, and source information of varying degrees of quality and accuracy.
C. John Clements, Glenda L. Lawrence, Kristine K. Macartney   +2 more
openaire   +2 more sources

Vaccine safety beliefs in the state of Alaska

Public Health in Practice
Objectives: Identifying the key factors associated with vaccine hesitancy remains a challenge as has been highlighted throughout the COVID-19 vaccine roll out and pandemic.
R. David Parker, Jennifer A. Meyer
doaj   +1 more source

Demonstration of safety and enhanced seroprotection against hepatitis B with investigational HBsAg-1018 ISS vaccine compared to a licensed hepatitis B vaccine

, 2012
Adults 40 years of age and older have been shown to be hypo-responsive immunologically to the currently available hepatitis B virus (HBV) vaccines. Three intramuscular doses of a Toll-like receptor 9 agonist, 1018 immunostimulatory sequence (1018 ISS ...
안상훈
core